Luiza Johnson
Family Medicine · Kildeer, ILNPI 1659863991
Payments from drug & device makers
Across 77 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$240
- Novartis$160
- Pfizer$114
- Merck$82
- Lilly USA, LLC$76
- Biohaven Pharmaceutical Holding Company Ltd.$67
- plus $739 from 26 others
What the payments were for
- Food & beverage$1,477100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $240 |
| Novartis | 8 | $160 |
| Pfizer | 7 | $114 |
| Merck | 5 | $82 |
| Lilly USA, LLC | 3 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $67 |
| Mannkind Corporation | 3 | $60 |
| Bayer | 3 | $56 |
| AbbVie | 3 | $55 |
| GSK | 3 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $47 |
| Dexcom, Inc. | 1 | $47 |
| Zealand Pharma US, Inc. | 2 | $37 |
| Boehringer Ingelheim | 2 | $33 |
| Amgen | 2 | $29 |
| Tandem Diabetes Care, Inc. | 1 | $28 |
| Edwards Lifesciences | 1 | $26 |
| Myovant Sciences Inc. | 1 | $24 |
| Medtronic | 1 | $24 |
| Lexicon Pharmaceuticals, Inc. | 1 | $22 |
| Ascensia Diabetes Care US Inc. | 1 | $22 |
| Boston Scientific | 1 | $20 |
| Exeltis, USA Inc. | 1 | $20 |
| Global Blood Therapeutics, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Abbott | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Shield Therapeutics Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $12 |
How this compares
$1,477 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 104 | $1,355 |
| Amlodipine Besylate | 103 | $750 |
| Rosuvastatin Calcium | 43 | $723 |
| Metoprolol Succinate | 32 | $701 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 13 | $687 |
| Levothyroxine Sodium | 51 | $594 |
| Lisinopril | 58 | $519 |
| Losartan Potassium | 44 | $511 |
| Gabapentin | 24 | $469 |
| Escitalopram Oxalate | 25 | $413 |
| Fluticasone Propionate | 22 | $378 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $350 |
| Omeprazole | 25 | $324 |
| Pregabalin | 18 | $262 |
| Pantoprazole Sodium | 29 | $246 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kildeer
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.